Linked Life Data

16455538

Source:http://linkedlifedata.com/resource/pubmed/id/16455538

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16455538rdf:typepubmed:Citationlld:pubmed
pubmed-article:16455538lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:16455538lifeskim:mentionsumls-concept:C0017638lld:lifeskim
pubmed-article:16455538lifeskim:mentionsumls-concept:C0914912lld:lifeskim
pubmed-article:16455538lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:16455538lifeskim:mentionsumls-concept:C0441800lld:lifeskim
pubmed-article:16455538lifeskim:mentionsumls-concept:C1521733lld:lifeskim
pubmed-article:16455538lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:16455538lifeskim:mentionsumls-concept:C1707520lld:lifeskim
pubmed-article:16455538lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:16455538lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:16455538pubmed:issue4lld:pubmed
pubmed-article:16455538pubmed:dateCreated2006-2-3lld:pubmed
pubmed-article:16455538pubmed:abstractTextIn clinical practice there is a difference in response of the blood-tumour barrier (BTB) permeability induced by bradykinin in brain tumours with the same pathology. The variability in response of tumours to bradykinin is likely to be related to the expression level of bradykinin B(2) receptor. This study used fresh human glioma samples to determine the expression level of bradykinin B(2) receptor on gliomas with different pathological grades. The grade of tumour was classified using the WHO classification. To determine the bradykinin B(2) receptor expression level in gliomas, Immunohistochemistry and Western blot methods were used. In 24 cases of gliomas there were eight cases of WHO I glioma, eight cases of WHO II glioma and eight cases of WHO III glioma. Both Western blot and immunohistochemistry showed bradykinin B(2) receptors localized on tumour cells, whilst brain cells at the edge of the glioma hardly expressed B(2) receptor. There were significant differences of bradykinin B(2) receptor expression level among different pathological grades of glioma. The expression of B(2) receptor in the three grades of glioma was in the order of WHO I < WHO II < WHO III. Determination of bradykinin B(2) receptor expression level in human glioma may be useful in screening glioma patients to predict whether they will be suitable for opening of the blood - tumour barrier with bradykinin or its analogue.lld:pubmed
pubmed-article:16455538pubmed:languageenglld:pubmed
pubmed-article:16455538pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16455538pubmed:citationSubsetIMlld:pubmed
pubmed-article:16455538pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16455538pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16455538pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16455538pubmed:statusMEDLINElld:pubmed
pubmed-article:16455538pubmed:monthAuglld:pubmed
pubmed-article:16455538pubmed:issn0268-8697lld:pubmed
pubmed-article:16455538pubmed:authorpubmed-author:LiY PYPlld:pubmed
pubmed-article:16455538pubmed:authorpubmed-author:WangPingPlld:pubmed
pubmed-article:16455538pubmed:authorpubmed-author:WangYuqinYlld:pubmed
pubmed-article:16455538pubmed:authorpubmed-author:AnPingPlld:pubmed
pubmed-article:16455538pubmed:authorpubmed-author:LiuYunhuiYlld:pubmed
pubmed-article:16455538pubmed:authorpubmed-author:ZhaoYisongYlld:pubmed
pubmed-article:16455538pubmed:authorpubmed-author:XueYixueYlld:pubmed
pubmed-article:16455538pubmed:authorpubmed-author:JiangNaijiaNlld:pubmed
pubmed-article:16455538pubmed:authorpubmed-author:YangZhihangZlld:pubmed
pubmed-article:16455538pubmed:issnTypePrintlld:pubmed
pubmed-article:16455538pubmed:volume19lld:pubmed
pubmed-article:16455538pubmed:ownerNLMlld:pubmed
pubmed-article:16455538pubmed:authorsCompleteYlld:pubmed
pubmed-article:16455538pubmed:pagination322-6lld:pubmed
pubmed-article:16455538pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:16455538pubmed:meshHeadingpubmed-meshheading:16455538...lld:pubmed
pubmed-article:16455538pubmed:meshHeadingpubmed-meshheading:16455538...lld:pubmed
pubmed-article:16455538pubmed:meshHeadingpubmed-meshheading:16455538...lld:pubmed
pubmed-article:16455538pubmed:meshHeadingpubmed-meshheading:16455538...lld:pubmed
pubmed-article:16455538pubmed:meshHeadingpubmed-meshheading:16455538...lld:pubmed
pubmed-article:16455538pubmed:meshHeadingpubmed-meshheading:16455538...lld:pubmed
pubmed-article:16455538pubmed:meshHeadingpubmed-meshheading:16455538...lld:pubmed
pubmed-article:16455538pubmed:meshHeadingpubmed-meshheading:16455538...lld:pubmed
pubmed-article:16455538pubmed:meshHeadingpubmed-meshheading:16455538...lld:pubmed
pubmed-article:16455538pubmed:meshHeadingpubmed-meshheading:16455538...lld:pubmed
pubmed-article:16455538pubmed:meshHeadingpubmed-meshheading:16455538...lld:pubmed
pubmed-article:16455538pubmed:meshHeadingpubmed-meshheading:16455538...lld:pubmed
pubmed-article:16455538pubmed:meshHeadingpubmed-meshheading:16455538...lld:pubmed
pubmed-article:16455538pubmed:meshHeadingpubmed-meshheading:16455538...lld:pubmed
pubmed-article:16455538pubmed:meshHeadingpubmed-meshheading:16455538...lld:pubmed
pubmed-article:16455538pubmed:meshHeadingpubmed-meshheading:16455538...lld:pubmed
pubmed-article:16455538pubmed:year2005lld:pubmed
pubmed-article:16455538pubmed:articleTitleStudy of correlation between expression of bradykinin B2 receptor and pathological grade in human gliomas.lld:pubmed
pubmed-article:16455538pubmed:affiliationDepartment of Neurobiology, China Medical University, Shenyang, Liaoming Province, Peoples Republic of China.lld:pubmed
pubmed-article:16455538pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16455538pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed